Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Injectable platelet-rich fibrin therapy improved hair and scalp conditions in women with excessive hair loss.

Flutamide effectively treats female pattern hair loss long-term with low doses being safe for the liver.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Ixekizumab has known and some unexpected side effects.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

A young woman recovered well from rare simultaneous Hepatitis B and autoimmune hepatitis after treatment.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Pexidartinib often causes liver issues and fatigue, especially in women.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.